About Sano Genetics
Sano Genetics is a Healthcare company based in San Francisco (United States) founded in 2018 by Patrick Short, Charlotte Guzzo, and William Jones. Sano Genetics is engaged in supporting precision medicine research. It operates on a Professional Services and Data-as-a-Service model. Sano Genetics has raised $26.47 million across 6 funding rounds from investors including Seedcamp, Cambridge Enterprise and University of Cambridge. The company has 10 employees. Its chief executive, as recorded, is Patrick Short. Its website sanogenetics.com draws about 24 thousand monthly visits. Sano Genetics offers products and services including Recruitment Support, DNA Testing, Patient Engagement, Electronic Medical Record Retrieval, and Prescreening and Digital Consent. Its focus areas include Biotechnology and Precision Medicine. Its competitors include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Sano Genetics is involved in facilitating precision medicine studies by providing a comprehensive platform for clinical research. Services offered include patient recruitment, DNA testing, electronic medical record retrieval, and participant engagement. The company operates in the healthcare sector, focusing on biotechnology and precision medicine solutions. Workflows are automated to streamline operations for sponsors, CROs, and research sites. Emphasis is placed on privacy and security with compliance to ISO27001, HIPAA, and GDPR standards. Support is extended to novel biomarker discovery and genetic testing programs for various conditions.
- Headquarters San Francisco, United States
- Employees 10
- Founders Patrick Short, Charlotte Guzzo, William Jones
- SectorsHealthcare
- Website sanogenetics.com
- Social LinkedIn X Facebook Instagram
- Annual Revenue$2.43 M (USD)45as on Dec 31, 2022
- Net Profit$244 K (USD)101as on Dec 31, 2022
- Total Equity Funding$26.47M (USD)
in 6 rounds
- Latest Funding Round$11.4M (USD), Series A
Jan 2024
- InvestorsSeedcamp
& 17 more
- Employee Count10
Products & Services of Sano Genetics
Sano Genetics offers a comprehensive portfolio of products and services, including Recruitment Support, DNA Testing, Patient Engagement, Electronic Medical Record Retrieval, and Prescreening and Digital Consent.
Support for patient recruitment in clinical studies is provided.
At-home DNA testing for patients is managed comprehensively.
Customized communication to engage participants in studies is offered.
Medical history retrieval for research purposes is facilitated efficiently.
Streamlined process for screening and consenting participants is provided.
Funding Insights of Sano Genetics
Sano Genetics has successfully raised a total of $26.47M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $11.4 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.47M
- Total Rounds 6
- Last Round Series A — $11.4M
- Investors Count 18
All 6 funding rounds of Sano Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $11.4M | Series A | – | Plural | |
| Aug 2023 | $419,255 | Grant | – | – | – |
| Mar 2022 | $11M | Series A | – | MMC Ventures | |
| Jan 2021 | $3.42M | Seed | – | Episode 1 Ventures | |
| Apr 2019 | Grant | – | – | ||
| Apr 2019 | $652,756 | Seed | – | Seedcamp, Cambridge Enterprise |
18 investors in total: 10 institutional and 8 angel.
Investors in Sano Genetics
Sano Genetics has secured backing from 18 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Seedcamp, Cambridge Enterprise and University of Cambridge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment support is offered to ambitious founders across Europe. | pluralplatform.com | London, United Kingdom | ||
Seed and series-A investments are made in technology companies. | mmc.vc | London, United Kingdom | ||
Seed & early-stage tech-focused venture capital firm | episode1.com | London, United Kingdom | ||
Venture capital fund investing in tech startups | 2007 | seedcamp.com | London, United Kingdom | |
Early-stage US tech companies are invested in by Synetro Group. | synetro.com | Chicago, United States | ||
Early-stage venture capital is provided to outlier founders. | january.ventures | |||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Multiple courses and degrees are offered across diversified academic streams. | 1209 | cam.ac.uk | Cambridge, United Kingdom | |
Genomics and biodata research is conducted at specialized labs. | 1994 | wellcomegenomecampus.org | Cambridge, United Kingdom | |
Provider of intellectual property management and technology consulting services | 2006 | enterprise.cam.ac.uk | Cambridge, United Kingdom |
Investor details for Sano Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sano Genetics
32 people are tracked at Sano Genetics (14 in leadership, 1 in board & advisors, 17 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Patrick Short | Co-Founder & CEO | Leadership |
Charlotte Guzzo | Co-Founder & COO | Leadership |
William Jones | Co-Founder & CTO | Leadership |
Liam Eves | Vice President Clinical Operations | Leadership |
Mina Frost | Vp, Operations And General Counsel | Leadership |
Kathy Reagan Young | Patient Recruitment Partner | Leadership |
Lisa Conroy, MPH | Director Of Marketing | Leadership |
Julian Moxon | Director Of Business Development & Revenue Operations | Leadership |
Becca Grant | Talent Partner | Leadership |
Laurence Hodgkins | Head Of Finance | Leadership |
Kendall Davis | Head Of Clinical Engagement | Leadership |
Velko Tonev | Commercial Director | Leadership |
Lauren Wong | Head Of Marketing | Leadership |
Benjamin Jackson | VP Of Commercial | Leadership |
Paul Forster | Investor and Board Member | Board & advisors |
Jane Ready-Webster | Senior Executive Assistant | Team |
Storm Johnson | Senior Business Development Representative | Team |
Sophie Gryntus | Events Specialist | Team |
Georgia Hingston | Senior Writer | Team |
Hadley Sheppard | Strategic Account Executive | Team |
12 more people are available in the full profile.
Complete people profiles for Sano Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sano Genetics
3 dated milestones of Sano Genetics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Sano Genetics is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $11.4M.
Competitors of Sano Genetics
Sano Genetics has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. |
Detailed competitors of Sano Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sano Genetics
The website of Sano Genetics (sanogenetics.com) receives about 23.6K visits a month.
- Monthly visits23.6K
▼ 10.9% vs previous month
Websites whose visitors overlap most with Sano Genetics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| insideprecisionmedicine.com | 100% | #507,293 | View details | ||
| subjectwell.com | 81% | 5.1K | #3,457,861 | View details | |
| obviohealth.com | 81% | 11.2K | #2,240,692 | View details | |
| credevo.com | 72% | 13K | #2,544,661 | View details | |
mybrainguide.org | mybrainguide.org | 69% | #1,173,209 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Sano Genetics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Sano Genetics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sano Genetics
Complete news archive for Sano Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sano Genetics
Sano Genetics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Sano Genetics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Patrick Short is the CEO of Sano Genetics, as recorded in our data. They have also founded this company.
Sano Genetics is a funded company, having raised a total of $26.47M across 6 funding rounds to date.
Sano Genetics has 10 employees.
Annual revenue of Sano Genetics is $2.43M as on Dec 31, 2022.
Sano Genetics is involved in facilitating precision medicine studies by providing a comprehensive platform for clinical research. Services offered include patient recruitment, DNA testing, electronic medical record retrieval, and participant engagement. The company operates in the healthcare sector, focusing on biotechnology and precision medicine solutions. Workflows are automated to streamline operations for sponsors, CROs, and research sites. Emphasis is placed on privacy and security with compliance to ISO27001, HIPAA, and GDPR standards. Support is extended to novel biomarker discovery and genetic testing programs for various conditions.
Sano Genetics's top competitors include Poseida Therapeutics, Denali Therapeutics and Castle Biosciences.
Sano Genetics offers Recruitment Support, DNA Testing, Patient Engagement, Electronic Medical Record Retrieval, and Prescreening and Digital Consent.
Sano Genetics has 18 investors. Key investors include Seedcamp, Cambridge Enterprise, University of Cambridge, Wellcome Genome Campus, and Plural.